The results are significant because they show that C. parvum responds to changes in the 30 intestinal microenvironment induced by a nutritional supplement.
to the present study, research with mice showed that supplementation of diet with kefir 75 exacerbated the outcome Clostridium difficile infection (17) . Indicating that a harmful effect of probiotics is unusual, no other studies in rodent or mammalian models demonstrating increased susceptibility to infection appear to have been published.
We previously reported a significant impact of cryptosporidiosis on the profile of the bacterial intestinal microbiota (18). Replicated experiments with two C. parvum isolates 80 comprising two infected and two control groups of mice revealed that the intestinal microbiota of infected animals differed from that of uninfected animals regardless of the C. parvum isolate. A taxonomic analysis of bacterial taxa highlighted two unclassified Bacteroidetes operation taxonomic unit (OTUs), Prevotellaceae and Porphyromonadaceae as overrepresented in the feces of infected mice, whereas OTUs most over-represented in uninfected mice were classified 85 as Porphyromonadaceae and one unclassified Bacteroidetes OTU. With an eye on developing alternative treatments, the experiments described here were aimed at assessing whether probiotics can influence the course cryptosporidiosis. Although the results reveal a significant trend for more severe infection, the results show that C. parvum proliferation responds to changes in the intestinal microbiota. These observations open the way for targeted editing of the 90 intestinal microbiota (19) (20) (21) as a low-cost approach to reducing the impact of cryptosporidiosis.
Results

Probiotic increases severity of infection.
To test for a probiotic effect on the severity of C. parvum infection, fecal oocyst output was 95 measured by flow cytometry as described above. In experiment 1, a total of 92 oocyst concentration values were acquired from 16 mice and six timepoints over a 15-day period. In experiment 2, 79 datapoints were obtained from the same number of mice (Fig. 1) . In experiment oocysts/g for the control mice (n=48). The difference between treatments was highly significant (Mann-Whitney U=541, p<0.001). An analogous significant probiotic effect was obtained for experiment 2; meanprobiotic=378,736 oocysts/g, nprobiotic=37, meancontrol=68,778 oocysts/g, ncontrol=42; U=269.5, p<0.001). Fig. 1 shows the pattern of oocyst output for the two experiments 110 plotted on a log scale. In experiment 1, due to early mortality and high oocyst output, the concentration of dexamethasone in the water was lowered from 16 mg/l to 10 mg/l on day 8. This intervention is the likely cause of the reduction in oocyst output. Mouse mortality appeared to be unrelated to probiotic treatment, but the numbers are too small to support statistical testing.
In experiment 1, two mice out of 16 died during the experiment; one mouse from treatment 115 group 1 on day 8 PI, and one mouse from control group 1 on day 15 PI. In experiment 2 two mice died, from treatment group 2 on day 16 PI and one from control group 1 on day 14 PI.
Probiotic treatment significantly impacts fecal microbiota.
To assess whether probiotic treatment impacted the fecal microbiota, pairwise weighted UniFrac 120 distances (22) between sequence data from 64 experiment 1 fecal samples were visualized on a PCoA plot (Fig. 2) . Samples collected starting on day 5 of probiotic treatment (day 4 PI) until day 16 of treatment (day 15 PI) were included. The number of samples in this analysis is smaller than shown in Fig. 1 , because not all fecal samples were sequenced. Consistent with an impact of probiotic consumption on the profile of the intestinal microbiota, this analysis revealed a non-125 overlapping distribution of datapoints according to treatment. ANOSIM was used to check the significance of sub-structuring by treatment. The test returned a highly significant R value of 0.305 (p<10 -5 ). Analogous results were obtained for experiment 2 based on 55 samples collected starting on day 10 after probiotic treatment was initiated (day 9 PI) until day 20 (day 19 PI). As for experiment 1, clustering by treatment was significant (R = 0.210, p<10 -5 ). 
Bacterial α-diversity does not correlate with oocyst output.
Having detected an impact of probiotic consumption on oocyst output and on the fecal 145 microbiota, the FCM and 16S data were analyzed jointly to identify possible associations between bacterial microbiota profile and severity of cryptosporidiosis. These combined analyses included all samples for which 16S and FCM data were acquired. A total of 44 samples were included in each experiment. As dysbiosis is typically characterized by low bacterial diversity and is often associated with increased susceptibility to enteric infections (23), the first global analysis examined 16S sequence data and oocyst concentration for a possible correlation between microbiota α-diversity and total oocyst output (Fig. 3) . Regardless whether all data were No association between these variables was identified in either experiment (Rxy=0.12, n=44, p=0.055 and Rxy=0.058, n=53, p=0.28) . Together with the results shown in Fig. 3 , these analyses indicate that higher oocyst output is not correlated with a global change in the microbiota.
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RDA was used as the second global analysis to assess whether fecal oocyst concentration significantly correlated with microbiota profile and identifying bacterial OTUs correlating in relative abundance with oocyst output. In experiment 1 a Monte Carlo test involving 1000 permutations of the 44 samples indicated a significant correlation between oocyst concentration and OTU profile (pseudo-F=1.0, p=0.014). This effect remains significant (F=2.7, p=0.024) after 175 accounting for treatment, i.e., defining treatment (±probiotic) as covariate, or accounting for "mouse" (defining mouse as covariate; pseudo-F=3.8, p=6x10 -5 ). The analogous test in experiment 2 also returned a significant pseudo-F ratio of 4.2 (n=44, p=0.0016). If removing the effect of treatment or "mouse" by defining each variable as covariate, the association remains significant (pseudo-F=2.6; p=0.015 and pseudo-F=5.2; p=3x10 -4 , respectively).
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High abundance of facultative anaerobes in severe infections.
Having identified a significant correlation between fecal oocyst concentration and OTU profile, the taxonomic make-up of the fecal microbiota was examined in more detail with the goal of identifying bacterial taxa which correlate in abundance with oocyst output. First we used 185 program LEfSe (24) to identify OTUs which significantly define the difference between samples containing high and low oocyst concentration. This analysis was based on 20 samples for each experiment, 10 samples with the highest oocyst concentration and 10 samples with the lowest concentration. In experiment 10, 7/10 samples in the high-oocyst group originated from mice treated with probiotics and 7/10 samples in the low-oocyst group came from control mice square=3.2, p=0.07). In experiment 11, 9/10 samples in the high-oocyst group originated from treated mice and 8/10 samples in the low-oocyst group originated from control mice (Chisquare=9.9, p=0.002). Feces from highly infected animals were characterized by a high Proteobacteria abundance, whereas feces from lightly infected animals were significantly enriched for Firmicutes. As observed for the impact of the probiotic on the severity of 195 cryptosporidiosis ( Fig. 1 ) and on the global microbiota profile (Fig. 2) , a clear similarity was observed between the two experiments ( Fig. 4) . that severe infection leads to a convergence of the microbiota, towards an increase in the relative abundance of Proteobacteria and a reduction in Firmicutes.
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Loss of microbiota functional diversity in heavily infected mice.
To extend the observed taxonomic differences between severely and lightly infected mice to the metagenome, program PICRUSt (29) was used to infer microbiota function from OTU profiles.
Given the more severe infection in experiment 2, metagenome analyses are only reported for this experiment. PICRUSt identified 39 KEGG level 2 categories in the combined metagenome. A As for the taxonomy analysis described above, we conclude from these results that proliferation 260 of C. parvum leads to a convergence of the inferred bacterial metagenome.
As described above for the taxonomy analysis, LEfSe was used to identify KEGG pathways which differ significantly in abundance between the 10 samples from highly infected and the same number of samples from lightly infected mice. Underscoring the difference at the metagenome level between fecal samples from severely and mildly infected mice, 22 of 39 265 KEGG level 2 pathways were significantly different between the two groups (Table S1 ). In comparison to the severely infected mice, the microbiota of mild infections was characterized by a high abundance of pathways related to replication, such as carbohydrate, amino acid and nucleic acid metabolism. These results extend the taxonomy presented in Fig. 4 , suggesting that the mouse dysbiotic cryptosporidiosis metagenome is selected for other functions than bacterial 270 replication.
Discussion
In a comprehensive review of the literature, Kristensen et al. (30) found a small number of publications describing randomized controlled probiotics trials which included the 275 characterization of fecal microbiota. The surprising conclusion of this survey is that no publications reported a significant change in the microbiota based on OTU richness, evenness or diversity analysis. Although our experiments were not designed to assess the probiotics' impact on the microbiota, we did find a significant probiotic effect. However, as no uninfected groups treated with probiotics were included, the change in microbiota profile could be related to the 280 severity of cryptosporidiosis rather than a direct impact of consumption of probiotics. Our focus was not to model the impact of probiotics on the gut ecosystem, but to assess whether probiotics can mitigate the severity of cryptosporidiosis.
As we do not observe a significant increase in probiotic bacteria in the feces of treated mice, we postulate that some of the bacterial or prebiotic ingredients present in the probiotic Although the proliferative stages of the parasite are intracellular, sporozoites, merozoites and microgametes are extracellular. Selective inhibition or promotion of oxygen-consuming bacteria (19) to temporarily raise or deplete luminal O2 (20) could potentially be investigated to assess the response of C. parvum and explore indirect approaches to mitigating the severity and duration of cryptosporidiosis through microbiota manipulation.
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Few studies have reported on the effect of diet on C. parvum infection. Liu et al. (44) found that protein deficiency increases the concentration of C. parvum DNA in feces. However, the difference between normal and protein-deficient animals was reported at 20 h post-infection.
Since C. parvum is not known to complete its life cycle in less than 72 h (45), the diet effect is difficult to interpret. A second study found a positive effect of pomegranate extract on Although the results of experiment 1 and experiment 2 are consistent, differences were also noticed. Most notably, average oocyst output in experiment 2 was higher, indicative of a more severe infection. Corroborating the model discussed above, more severe infections were associated with higher relative abundance of Gammaproteobacteria (Fig. 4) . The reason for the 335 difference between severity of infection is hard to determine, but the different route of dexamethasone administration mentioned above could have contributed to this outcome. The use of two C. parvum isolates is unlikely to be a relevant factor as MD and TU114 are not known to differ with respect to their virulence phenotype in dexamethasone treated mice (unpublished observations). Differences in fecal oocyst output between co-housed mice was also observed 340 ( Fig. 1) . As described in Materials and Methods, animals from a same cage were housed individually only for 16 h three times a week for collection of feces, but were otherwise housed together in two cages per treatment or 4 cages for each experiment. The difference in oocyst output and microbiota profile between cagemates is difficult to explain given the close contact between animals. This phenomenon justifies mice to be sampled individually, rather than 345 sampling by group as is common practice.
Conclusions
In the absence of effective anti-protozoal drugs to control cryptosporidiosis, alternative treatments are attractive. However, our current understanding of how microbiota perturbation, whether induced by diet, pro-, anti-or prebiotics, affects enteric pathogens including
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Cryptosporidium is very incomplete. Identifying specific mechanisms impacting pathogen virulence in response to probiotics consumption or diet may enable the development of targeted microbiota editing measures to mitigate the severity of cryptosporidiosis. Methods designed to detect metabolome modifications (47) will be needed to supplement the information gained from 16S amplicon sequencing. Lastly, enhancing the value of the rodent cryptosporidiosis model, the 355 observed shift towards facultative anaerobes indicates common pathogenic changes in the human and rodent intestine in response to enteric infections.
Materials and Methods
Parasites
360
Oocysts from C. parvum isolate MD (48) or TU114 (49) were used in experiment 1 and 2, respectively. MD is a zoonotic isolate, whereas TU114 belong to the anthroponotic subgroup characterized by a IIc GP60 genotype (50) . Oocysts were purified from mouse feces on gradients of Nycodenz (Alere Technologies, Oslo, Norway) as described (51). The age of the oocysts was 13 and 110 days for experiment 1 and 2, respectively.
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Mouse experiments.
To test the effect of a commercially available probiotic, two replicate experiments were conducted in mice. In each experiment, herein referred to as experiment 1 and experiment 2, respectively, 16 female CD-1 mice approximately 6 weeks of age were used. Upon delivery, 370 each mouse was individually tagged and randomly assigned to one of four groups of four mice.
Mice were immunosuppressed by adding dexamethasone 21-phosphate disodium (Sigma, cat no. D1169) to the drinking water at a concentration of 16 mg/l (52) starting on the day of arrival, defined here as day -7 post-infection (PI), i.e., 7 days prior to infection. To deplete the native intestinal microbiota, vancomycin and streptomycin were added to the drinking water at a 375 concentration of 500 mg/l and 5 g/l, respectively, starting on day -6 PI. Metronidazole at a dose of 20 mg/kg was given daily by gavage starting on day -6 PI. The antibiotic treatment was discontinued on day -2 PI. Starting on day -1 PI, the drinking water was supplemented with 1.3 g of probiotic added to 500 ml water. This product contains 15 bacterial strains belonging to the genera Bifidobacter (4 species), Lactobacillus (9 species) and Streptococcus thermophilus. In 380 addition to bacteria, 1 g of product contains 8 mg Acacia gum, 540 mg Larch gum, 115 mg galactooligosaccharide, 212 mg L-glutamine and 150 IU vitamin D3. When dissolved into 500 ml of water, the final concentration of these ingredients was 20 μg/ml, 1.4 mg/ml, 0.3 mg/ml, 0.55 mg/ml and 0.4 IU/ml, respectively. The product is flavorless. Drinking water with dexamethasone and probiotic water was replaced every 3 days. Mice were orally infected on day C. parvum oocysts. In experiment 1, to compensate for increased water uptake in the two groups receiving probiotic, the concentration of dexamethasone phosphate in the water of the two treated groups was reduced to 10 mg/l starting on day 10 PI. In experiment 2, to avoid possible differences in dexamethasone uptake with drinking water, the drug (Dexamethasone; Sigma, cat no. D1756) was given only subcutaneously 390 every second day starting on day 2 PI. A volume of 100 µl of 10 mg/ml dexamethasone suspension was injected alternatively into the right and left side of the abdomen. To obtain fecal pellets for microbiota analysis, mice were individually transferred to a 1-liter plastic beaker and pellets collected upon defecation. Pellets were stored at -20C. To collect feces for oocyst enumeration, mice were individually transferred overnight to collection cages fitted with a wire 395 bottom. Feces were collected from these cages were stored at 4C. In the morning, mice were returned to their respective group cage, such that they were housed individually for 14-16 h on the days when feces for oocyst enumeration were collected. While in conventional cages, the mice were always housed with the same cagemates.
Animal experiments adhered to the NIH Guide for the Care and Use of Laboratory 400 Animals and were approved by the Tufts University Animal Care and Use Committee.
Enumeration of oocysts.
Feces collected overnight were weighted, diluted 1:5 in distilled water and homogenized with a vortex. To remove debris, fecal homogenates were filtered through 100 μm cell strainers Specifically, the distance between sample A containing an oocyst concentration of xa/g feces and sample B containing a concentration of xb/g feces was calculated as (xa -xb) 2 . The accuracy of the flow cytometry oocyst enumeration method was evaluated by correlating the counts against the Cryptosporidium 18S ribosomal RNA gene copy number estimated using real-time PCR with published primers (54) . This analysis based on five randomly chosen experiment 1 samples 425 generated a correlation coefficient of 69%.
Microbiota analysis.
DNA was extracted from 10 mg of feces collected individually from each mouse. DNA was extracted in a QIACube instrument using the QIAamp PowerFecal DNA kit (QIAGEN, cat. are equivalent to the conserved 338R sequence (55) . One microliter of primary PCR reaction was subjected to a secondary PCR to incorporate a 6-nucleotide barcode using to each sample. The secondary amplification was as described (18) 
Bioinformatics.
FASTQ formatted sequences were processed using programs found in mothur (56) essentially as described (18). Briefly, random subsamples of 5000 sequences per sample were processed. This procedure is not expected to bias the analysis (57) Color indicates experimental group as described in Fig. 1 . Samples were collected from individual mice. bacterial taxa significantly associated with severity of infection were identified using LEfSe (24) in a comparison of ten samples with the highest (high) and lowest (low) oocyst concentration; twenty samples were included for each experiment. Color indicates phylum and color intensity genus or highest taxonomic level (family, order etc.) identified; green Proteobacteria; red, Firmicutes; blue, Actinobacteria. 
